Inicio › Sobrepeso › Alabama › Birmingham
Ensayos clínicos de Sobrepeso en Birmingham, AL
16 estudios para Sobrepeso buscan participantes en centros de Birmingham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
ReclutandoFase 3
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ReclutandoFase 2
- University of Alabama - Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Univ of Alabama Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
ReclutandoFase 3
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutandoFase 3
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutandoFase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 3
- AURORA-1 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutandoFase 3
- AURORA-2 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
ReclutandoFase 3
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ReclutandoFase 3Se aceptan voluntarios sanos
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
ReclutandoFase 3
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
ReclutandoFase 3
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutandoFase 3
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
Reclutando
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Reclutando
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Reclutando
- The Worship Center Cristian Church, Birmingham
Ensayos de Sobrepeso en otras ciudades
- San Antonio, TX34 estudios
- Houston, TX33 estudios
- Chicago, IL28 estudios
- Orlando, FL27 estudios
- Las Vegas, NV23 estudios
- Miami, FL23 estudios
- Atlanta, GA20 estudios
- Dallas, TX20 estudios
- New York City, NY19 estudios
- Jacksonville, FL19 estudios
- Washington, DC19 estudios
- Austin, TX18 estudios
Otros estudios en Birmingham
- Cáncer (todos los tipos)30 estudios
- Cáncer de seno24 estudios
- Obesidad23 estudios
- Cáncer de ovario23 estudios
- Cáncer de pulmón de células no pequeñas22 estudios
- Leucemia mielógena aguda21 estudios
- Mieloma múltiple18 estudios
- Enfermedad de obstrucción pulmonar crónica17 estudios
- Enfermedad cardiovascular17 estudios
- Cáncer de endometrio16 estudios
- Diabetes tipo 216 estudios
- Fibrosis quística16 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.